Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a Bayer HealthCare LLC supplemental NADA that provides for changing scientific nomenclature for a bovine respiratory pathogen on labeling for enrofloxacin injectable solution. To view this final rule, click here.
